FHL2 also interacts with a microtubule-associated protein 1 light chain 3 (LC3) regulating the development of skeletal muscle cells (Liu et al., 2019), and with β-catenin to upregulate its transactivation activity in cancer cells (Wei et al., 2003). The gene discussed is MAP1LC3A; the disease is cancer.